These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001-2014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain). España PP; Uranga A; Ruiz LA; Quintana JM; Bilbao A; Aramburu A; Serrano L; Ayarza R; Martinez AP; Zalacain R Vaccine; 2019 Jun; 37(29):3840-3848. PubMed ID: 31153692 [TBL] [Abstract][Full Text] [Related]
3. Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy. Esposito S; Marchese A; Tozzi AE; Rossi GA; Da Dalt L; Bona G; Pelucchi C; Schito GC; Principi N; Pediatr Infect Dis J; 2012 Jul; 31(7):705-10. PubMed ID: 22426300 [TBL] [Abstract][Full Text] [Related]
4. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--over 22 years. Jacups SP; Cheng A Vaccine; 2011 Jul; 29(33):5386-92. PubMed ID: 21651943 [TBL] [Abstract][Full Text] [Related]
5. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia. Kang CI; Song JH; Kim SH; Chung DR; Peck KR; Thamlikitkul V; Wang H; So TM; Hsueh PR; Yasin RM; Carlos CC; Van PH; Perera J J Infect; 2013 Jan; 66(1):34-40. PubMed ID: 22922634 [TBL] [Abstract][Full Text] [Related]
6. Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness. Iroh Tam PY; Hanisch BR; Forward B Clin Pediatr (Phila); 2015 Jun; 54(6):591-3. PubMed ID: 25500500 [TBL] [Abstract][Full Text] [Related]
7. [Bacteremic pneumococcal pneumonia]. Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543 [TBL] [Abstract][Full Text] [Related]
8. Decrease in drug resistance in pneumococcal community-acquired pneumonia. Obando I; Arroyo L; Sanchez-Tatay D Chest; 2007 Jul; 132(1):359; author reply 359-60. PubMed ID: 17625101 [No Abstract] [Full Text] [Related]
10. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Toltzis P; Jacobs MR Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653 [TBL] [Abstract][Full Text] [Related]
11. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases. Watanakunakorn C; Bailey TA Arch Intern Med; 1997 Sep; 157(17):1965-71. PubMed ID: 9308508 [TBL] [Abstract][Full Text] [Related]
12. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine. de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137 [TBL] [Abstract][Full Text] [Related]
13. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Albrich WC; Baughman W; Schmotzer B; Farley MM Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400 [TBL] [Abstract][Full Text] [Related]